Skip to main content

Table 1 Clinical characteristics of 241 HCC patients underwent hepatectomy

From: Anatomical sites (Takasaki’s segmentation) predicts the recurrence-free survival of hepatocellular carcinoma

Variables

Training cohort (n = 211)

Internal validation cohort (n = 30)

Age (years)

50.0 ± 11.4

50.0 ± 13.1

Gender, M: F

200:11

26:4

HBsAg

  

 Positive

203 (96.2%)

28 (93.3%)

 Negative

8 (3.8%)

2 (6.7%)

AFP (ng/ml)

380.4 ± 519.4

326.3 ± 455.2

Platelet count (109/L)

175.3 ± 78.8

202.3 ± 86.6

Prothrombin time (s)

13.6 ± 1.3

13.5 ± 1.3

Total bilirubin (μmol/L)

17.6 ± 13.2

14.7 ± 9.4

Albumin (g/L)

39.8 ± 4.4

39.6 ± 4.8

Alanine aminotransferase (U/L)

48.6 ± 42.7

48.9 ± 28.7

Child–Pugh score

  

 A

210 (99.5%)

28 (93.3%)

 B

1 (0.5%)

2 (6.7%)

  1. AFP alpha-fetoprotein, HCC hepatocellular carcinoma